PLENARY SESSION: Hematopoietic stem cells (HSCs) are programmed by metabolic changes which can alter how they work. NHLBI-funded research finds that varying prenatal folate status metabolically programs HSCs during development bit.ly/3RkzFO0 #ASH23

PLENARY SESSION: Learn more about a multi-country prospective trial of hydroxyurea for children with #SickleCellAnemia in sub-Saharan Africa. bit.ly/47ViZC6

Don’t forget to stop by the #NHLBI booth (#2401) to learn about research, training, and career opportunities. go.nih.gov/LYS1cy8 #ASH23

As people with #SickleCellDisease age, they experience faster functional decline. Learn more about a new test to assess aging in #SCD at #ASH23. bit.ly/4a0WvBu

Hereditary hemorrhagic telangiectasia (HHT) is the second most common bleeding disorder worldwide. Learn about the exciting results from PATH-HHT, the largest and the first adequately powered, randomized trial of therapy for HHT at #ASH23. bit.ly/46wsaYR

Don’t miss results from a BMT CTN multi-center phase-II trial on hematopoietic stem-cell transplantation for treatment of #SickleCellDisease at this #ASH23 late-breaking abstract. bit.ly/49VH0Lj

Q&A with NIH NHLBI Director Dr. Gary Gibbons and myself talking about the historic importance of this medical milestone. #sicklecell #genetherapies nhlbi.nih.gov/news/2023/fda-…

.CMSGov announced plans to increase access to gene therapies for sickle cell disease. Just last week, an NHLBI-funded modeling study showed that these therapies are beneficial and likely cost-effective if the price stays below $2 million per person. bit.ly/3UtZqxc

NHLBI is on #LinkedIn! Follow our NHLBI Blood Research & Education page for the latest news, events, funding/training opportunities, and more: linkedin.com/showcase/nhlbi…

Register to attend NHLBI’s Annual #SickleCellDisease Research Meeting on Aug 12-14 to hear experts discuss the latest #SickleCell disease research developments. Register before 5pm ET on Jul 22 for in-person/hybrid or before 5pm ET on Aug 5 for virtual: bit.ly/3zBE0WN

Registration for the Sickle Cell Disease Advisory Committee is now open. 7/23 @ 3pm nih.zoomgov.com/webinar/regist…

New funding opportunity seeks applications to enhance training opportunities at institutions that have a documented historical institutional mission of educating underrepresented students from across the career development continuum. Learn more: bit.ly/3LwjJVn

New funding opportunity seeks applications to enhance training opportunities at institutions that have a documented historical institutional mission of educating underrepresented students from across the career development continuum. Learn more: bit.ly/3LwjJVn

This account will no longer be active as of Friday, November 1, 2024. For the latest news, events, funding/training opportunities, and more, follow our NHLBI Blood Research & Education Page: linkedin.com/showcase/nhlbi…

This account will no longer be active as of Friday, November 1, 2024. For the latest news, events, funding/training opportunities, and more, follow our NHLBI Blood Research & Education Page: linkedin.com/showcase/nhlbi…

This account will no longer be active as of Friday, November 1, 2024. For the latest news, events, funding/training opportunities, and more, follow our NHLBI Blood Research & Education Page: linkedin.com/showcase/nhlbi…

This account will no longer be active as of Friday, November 1, 2024. For the latest news, events, funding/training opportunities, and more, follow our NHLBI Blood Research & Education Page: linkedin.com/showcase/nhlbi…

This account will no longer be active as of Friday, November 1, 2024. For the latest news, events, funding/training opportunities, and more, follow our NHLBI Blood Research & Education Page: linkedin.com/showcase/nhlbi…

This account will no longer be active as of Friday, November 1, 2024. For the latest news, events, funding/training opportunities, and more, follow our NHLBI Blood Research & Education Page: linkedin.com/showcase/nhlbi…